These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8364928

  • 1. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice.
    Takagi H, Sharp R, Takayama H, Anver MR, Ward JM, Merlino G.
    Cancer Res; 1993 Sep 15; 53(18):4329-36. PubMed ID: 8364928
    [Abstract] [Full Text] [Related]

  • 2. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H, Sharp R, Hammermeister C, Goodrow T, Bradley MO, Fausto N, Merlino G.
    Cancer Res; 1992 Oct 01; 52(19):5171-7. PubMed ID: 1394122
    [Abstract] [Full Text] [Related]

  • 3. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE, Kaufmann WK, Sitaric S, Luetteke NC, Lee DC.
    Mol Carcinog; 1996 Mar 01; 15(3):183-9. PubMed ID: 8597531
    [Abstract] [Full Text] [Related]

  • 4. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S, Merlino GT, Ward JM.
    Carcinogenesis; 1994 Sep 01; 15(9):1791-8. PubMed ID: 7923571
    [Abstract] [Full Text] [Related]

  • 5. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM, Kao CY, Santoni-Rugiu E, Woitach JT, Jensen MR, Thorgeirsson SS.
    Cancer Res; 1997 Jun 01; 57(11):2089-95. PubMed ID: 9187100
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME, Pierce RH, Fausto N.
    Cancer Res; 2001 Jan 15; 61(2):594-601. PubMed ID: 11212255
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of alpha-tocopherol on hepatocarcinogenesis in transforming growth factor-alpha (TGF-alpha) transgenic mice treated with diethylnitrosamine.
    Kakizaki S, Takagi H, Fukusato T, Toyoda M, Horiguchi N, Sato K, Takayama H, Nagamine T, Mori M.
    Int J Vitam Nutr Res; 2001 Sep 15; 71(5):261-7. PubMed ID: 11725690
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF, Factor VM, Loi R, Thorgeirsson SS.
    Cancer Res; 2001 Mar 01; 61(5):2085-91. PubMed ID: 11280770
    [Abstract] [Full Text] [Related]

  • 20. Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.
    Nørgaard P, Law B, Joseph H, Page DL, Shyr Y, Mays D, Pietenpol JA, Kohl NE, Oliff A, Coffey RJ, Poulsen HS, Moses HL.
    Clin Cancer Res; 1999 Jan 01; 5(1):35-42. PubMed ID: 9918200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.